0
13

In This Issue
  |  
The American Journal of Psychiatry

August 01, 2008, Vol. 165, No. 8
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

   Listen to the Podcast | All Podcasts
In This Issue
In This Issue
Editorial
Cholinergic Agonists as Novel Treatments for Schizophrenia: The Promise of Rational Drug Development for Psychiatry
Jeffrey A. Lieberman, M.D.; Jonathan A. Javitch, M.D., Ph.D.; Holly Moore, Ph.D.
Neural Networks in Schizophrenia
John G. Csernansky, M.D.; Will J. Cronenwett, M.D.
New Insights Into Clinical Response in Schizophrenia: From Dopamine D2 Receptor Occupancy to Patients’ Quality of Life
Donald C. Goff, M.D.
Divergent Approaches Converge on Frontal Lobe Dysfunction in Schizophrenia
Daniel H. Mathalon, Ph.D., M.D.; Judith M. Ford, Ph.D.
Accelerating New Knowledge in Schizophrenia
Carol A. Tamminga, M.D.
Commentary
Clinically Responsible Genetic Testing in Neuropsychiatric Patients: A Bridge Too Far and Too Soon
David L. Braff, M.D.; Robert Freedman, M.D.
Reviews and Overviews
The Evolution of the Cognitive Model of Depression and Its Neurobiological Correlates
Aaron T. Beck, M.D.
Article
Relationship of Cognition and Psychopathology to Functional Impairment in Schizophrenia
Somaia Mohamed, M.D., Ph.D.; Robert Rosenheck, M.D.; Marvin Swartz, M.D.; Scott Stroup, M.D.; Jeffrey A. Lieberman, M.D.; Richard S.E. Keefe, Ph.D.
Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study
Gerhard Gründer, M.D.; Christine Fellows, M.D.; Hildegard Janouschek, M.D.; Tanja Veselinovic, M.D.; Christian Boy, M.D.; Anno Bröcheler, M.D.; Katrin M. Kirschbaum, Ph.D.; Sandra Hellmann; Katja M. Spreckelmeyer, Ph.D.; Christoph Hiemke, Ph.D.; Frank Rösch, Ph.D.; Wolfgang M. Schaefer, M.D., Ph.D.; Ingo Vernaleken, M.D.
Reduced Evoked Gamma Oscillations in the Frontal Cortex in Schizophrenia Patients: A TMS/EEG Study
Fabio Ferrarelli, M.D., Ph.D.; Marcello Massimini, M.D., Ph.D.; Michael J. Peterson, M.D., Ph.D.; Brady A. Riedner, B.S.; Mariana Lazar, Ph.D.; Michael J. Murphy, B.S.; Reto Huber, Ph.D.; Mario Rosanova, M.D., Ph.D.; Andrew L. Alexander, Ph.D.; Ned Kalin, M.D.; Giulio Tononi, M.D., Ph.D.
CME   Association of Dorsolateral Prefrontal Cortex Dysfunction With Disrupted Coordinated Brain Activity in Schizophrenia: Relationship With Impaired Cognition, Behavioral Disorganization, and Global Function
Jong H. Yoon, M.D.; Michael J. Minzenberg, M.D.; Stefan Ursu, M.D., Ph.D.; Ryan Walters, B.A.; Carter Wendelken, Ph.D.; J. Daniel Ragland, Ph.D.; Cameron S. Carter, M.D.
The Anatomy of First-Episode and Chronic Schizophrenia: An Anatomical Likelihood Estimation Meta-Analysis
Ian Ellison-Wright, M.R.C.P.; David C. Glahn, Ph.D.; Angela R. Laird, Ph.D.; Sarah M. Thelen, B.S.; Ed Bullmore, Ph.D.
Diffusion Tensor Imaging Findings in First-Episode and Chronic Schizophrenia Patients
Joseph I. Friedman, M.D.; Cheuk Tang, Ph.D.; David Carpenter; Monte Buchsbaum, M.D.; James Schmeidler, Ph.D.; Lauren Flanagan; Shana Golembo; Isabella Kanellopoulou, M.D.; Johnny Ng; Patrick R. Hof, M.D.; Philip D. Harvey, Ph.D.; Nicholas D. Tsopelas, M.D.; Daniel Stewart, M.D.; Kenneth L. Davis, M.D.
CME   Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
Anantha Shekhar, M.D., Ph.D.; William Z. Potter, M.D., Ph.D.; Jeffrey Lightfoot, Ph.D.; John Lienemann, D.Pharm.; Sanjay Dubé, M.D.; Craig Mallinckrodt, Ph.D.; Frank P. Bymaster, M.Sc.; David L. McKinzie, Ph.D.; Christian C. Felder, Ph.D.
Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
Robert Freedman, M.D.; Ann Olincy, M.D.; Robert W. Buchanan, M.D.; Josette G. Harris, Ph.D.; James M. Gold, Ph.D.; Lynn Johnson, Pharm.D.; Diana Allensworth, M.A.; Alejandrina Guzman-Bonilla, B.A.; Bettye Clement, M.S.W., Ph.D.; M. Patricia Ball, R.N.C., M.S.; Jay Kutnick, M.D.; Vicki Pender, B.S.; Laura F. Martin, M.D.; Karen E. Stevens, Ph.D.; Brandie D. Wagner, Ph.D.; Gary O. Zerbe, Ph.D.; Ferenc Soti, Ph.D.; William R. Kem, Ph.D.
Clinical Case Conference
CME   Schizophrenia in a Patient With Spinocerebellar Ataxia 2: Coincidence of Two Disorders or a Neurodegenerative Disease Presenting With Psychosis?
Matthew Rottnek, M.D.; Silvana Riggio, M.D.; William Byne, M.D, Ph.D.; Mary Sano, Ph.D.; Russell L. Margolis, M.D.; Ruth H. Walker, M.B.Ch.B., Ph.D.
Treatment in Psychiatry
Asperger’s Syndrome: Diagnosis and Treatment
Karen Toth, Ph.D.; Bryan H. King, M.D.
Letters to the Editor
Antidepressant Prescribing and Rapid Cycling
Mixed Depression and Rapid Cycling
Dr. Schneck and Colleagues Reply
d-Cycloserine Augmentation for Behavioral Therapy
Maimonides and Depression
Father-to-Son Transmission of 6;17 Translocation in Tourette’s Syndrome
The Use of Iconic Symbols to Represent Our Experience
Takotsubo Cardiomyopathy in a Patient With Emotional Stress
Book Forum
The Physician as Patient: A Clinical Handbook for Mental Health Professionals
Pain and Its Transformations: The Interface of Biology and Culture
The Accidental Mind: How Brain Evolution Has Given Us Love, Memory, Dreams, and God
Metabolic Syndrome and Psychiatric Illness: Interactions, Pathophysiology, Assessment, and Treatment
Images in Psychiatry
Franco Basaglia, 1924–1980
Giovanni de Girolamo, M.D.; Francesco Barale, M.D.; Pierluigi Politi, M.D.; Paolo Fusar-Poli, M.D.
Introspection
Eight Ball
Joshua L. Roffman, M.D.
Books Received
Am J Psychiatry 2008 165: 1058-1058
Official Actions
Am J Psychiatry 2008 165: 1059-1063
Am J Psychiatry 2008 165: 1064-1078
  |  
Copyright ©
American
Psychiatric
Association